September 16th 2025
CSL will fund Phase III clinical development of VMX-C001 with an option to acquire VarmX.
September 15th 2025
September 10th 2025
The Need for LBFs and Challenges in Oral Biologic Formulation (AAPS PharmSci 360)
October 22nd 2024Karunakar Sukuru, RPh, PhD, the global vice-president-Rx Product Development, Pharma and Consumer Health, at Catalent Pharma Solutions, discussed lipid-based formulations and tackling bioavailability challenges for oral biologics at AAPS PharmSci 360.
Sexy Science in Pharmaceuticals: Hot-Melt Extrusion
October 2nd 2024This premiere episode of Sexy Science in Pharmaceuticals features Professor Jonathan Pokorski, UC San Diego Jacobs School of Engineering, and Dr. James DiNunzio, Senior Principal Scientist at Merck & Co., Inc. in Rahway, NJ, discussing the benefits of hot-melt extrusion.